-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

Benzinga·02/05/2026 15:46:50
Listen to the news
Piper Sandler analyst Allison Bratzel maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight and raises the price target from $3 to $4.